Check our open funding & investment opportunities
REF 0825: Edtech and Medtech.
💲 Funding: Currently seeking a combination of non-dilutive financing and convertible notes.
✅ Cap Table: Following the close of a €1M pre-seed round, the Founders retain over 80% equity.
👥 Team: We have 10+ full-time staff and highly engaged top-tier advisors, some of whom have already invested.
📍 Location: Headquartered in Navarra, with presence in Barcelona and Madrid.
🔬🎓 Sector: We operate at the intersection of Medtech and Edtech.
🏢 Business Model: Highly scalable, accessible product with a large TAM (Total Addressable Market). Applicable globally to healthcare students/professionals (B2C) and clinics, hospitals & universities (B2B).
REF 0525: device for Alzheimer, Parkinson and neurodegeneration.
💲 100k-300k eur Investment Opportunity: Medical Device for Neurodegenerative Diseases.
🚀Funding sought to develop a medical device enhancing efficacy & safety of therapies for Alzheimer’s, Parkinson’s & related conditions.
✅ Already validated in animal models. 🔜 Now entering human clinical trials
✨ Early-stage investors can participate via a convertible loan note.
REF 0225: novel therapies with IA.
💲 Required Investment: 5,5M€ Series A round, in two parts: 2M€ in 2025 and 3,5M€ in 2026. Bridge round of up to 400k € in discounted convertible notes available until end of August 2025. Funds will cover preclinical development and manufacturing expenses required to advance the lead candidate to clinical trials in humans.
🚀 novel therapeutic products designed with support of cutting-edge IA tools. Innovative therapeutic approach with AI-designed compounds. Efficacy data in animal models already available. Return: anticipated 20x+ multiplier at exit for investors in this 2025 round. Exit planned for 2030.
🔬 Solid scientific foundation, great team, clear development roadmap and long-term vision.
📊 Global market, projected to surpass $44B by 2032.
REF 0325: chemical engineering and green Hydrogen.
💲 Required Investment: 750,000 €. Funds will cover cash flow for the development, there is a minimum viable product previously developed in collaboration with a Technology Center.
🚀Investment Opportunity in Chemical Engineering Project: Efficient Hydrolysis and Green Hydrogen Generation.
📈 Offered Return: 10% per annum on invested capital (from investment date), structured as debt with an option to convert into equity upon proven profitability.
🛡️ Guarantee: Established company with a solid track record and diversified operations. Holds a granted subsidy amounting to 2.8M €.
REF 0425: Health Artificial Intelligence.
💲 Required Investment: 150,000 €
🚀 Investment Opportunity in Health-tech & artificial intelligence. Innovative company with strong project portfolio and growth potential.
📈 Offered Return: 10% per annum on invested capital (from investment date).
🛡️ Guarantee: Company holds a pending VAT refund (reimbursement expected before end of July).
✅ Solid foundation and long-term vision.
REF 0525: novel extraction methods for marble quarry.
💲 Required investment: 105 M €. Advanced geological studies available. Technical feasibility confirmed (yield: 92% usable material).
🚀 Investment Opportunity in marble quarry, open-air with novel extraction methods, ready for production, 4-fold ROI expected within 2 years.
Link to video: https://dai.ly/k2DC8JizrTRuwjDi0Dk
📍 Exploitation concession currently active. High-potential mining concession active. Proven reserves of 20M tons of cream ivory marble, (premium grade, market value: 120-250 €/m³ as blocks).
Visual aid for optometrists and low-vision patients. REF: 0125
💲 Required Investment: 650,000 €. 📊 More info about the product: https://retiplus.com/en/
🚀 Investment Opportunity in Health-tech. Investment will cover international marketing and expansion.
📈 Offered Return: 15% per annum on invested capital (from investment date).
📍 Currently looking for novel distributors in any country (already selling in Europe, LATAM, EMEA).
✅ Solid team and long-term market.